CA Patent

CA2224333A1 — Method and apparatus for dermatology treatment

Assigned to Individual · Expires 1997-01-30 · 29y expired

What this patent protects

A laser treatment method is provided which removes vascular and pigmented lesions from the skin of a living human. The methodology involves a carefully designed treatment protocol utilizing a modified optical apparatus. The apparatus is a modified diode laser system, designed for…

USPTO Abstract

A laser treatment method is provided which removes vascular and pigmented lesions from the skin of a living human. The methodology involves a carefully designed treatment protocol utilizing a modified optical apparatus. The apparatus is a modified diode laser system, designed for optimal therapeutic selectivity.

Drugs covered by this patent

aminolevulinic-acid-hydrochloride (AMINOLEVULINIC ACID HYDROCHLORIDE)

Patent Metadata

Patent number: CA2224333A1
Jurisdiction: CA
Classification: —
Expires: 1997-01-30
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.